131 related articles for article (PubMed ID: 7763284)
1. Binding of [35S]adenosine 5'-O-(2-thiodiphosphate) to endothelial cells in culture.
Wilkinson GF; Boarder MR
Biochem Pharmacol; 1995 May; 49(10):1411-8. PubMed ID: 7763284
[TBL] [Abstract][Full Text] [Related]
2. Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations.
Schäfer R; Reiser G
Br J Pharmacol; 1997 Jul; 121(5):913-22. PubMed ID: 9222547
[TBL] [Abstract][Full Text] [Related]
3. Guanine nucleotide-sensitive interaction of a radiolabeled agonist with a phospholipase C-linked P2y-purinergic receptor.
Cooper CL; Morris AJ; Harden TK
J Biol Chem; 1989 Apr; 264(11):6202-6. PubMed ID: 2495280
[TBL] [Abstract][Full Text] [Related]
4. High affinity P2x-purinoceptor binding sites for [35S]-adenosine 5'-O-[3-thiotriphosphate] in rat vas deferens membranes.
Michel AD; Humphrey PP
Br J Pharmacol; 1996 Jan; 117(1):63-70. PubMed ID: 8825344
[TBL] [Abstract][Full Text] [Related]
5. The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase.
Webb TE; Feolde E; Vigne P; Neary JT; Runberg A; Frelin C; Barnard EA
Br J Pharmacol; 1996 Dec; 119(7):1385-92. PubMed ID: 8968547
[TBL] [Abstract][Full Text] [Related]
6. Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals.
Pintor J; Díaz-Rey MA; Miras-Portugal MT
Br J Pharmacol; 1993 Apr; 108(4):1094-9. PubMed ID: 8485620
[TBL] [Abstract][Full Text] [Related]
7. Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.
Mateo J; Miras-Portugal MT; Castro E
Br J Pharmacol; 1996 Nov; 119(6):1223-32. PubMed ID: 8937727
[TBL] [Abstract][Full Text] [Related]
8. Evidence that most high-affinity ATP binding sites on aortic endothelial cells and membranes do not correspond to P2 receptors.
Motte S; Swillens S; Boeynaems JM
Eur J Pharmacol; 1996 Jun; 307(2):201-9. PubMed ID: 8832222
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a P2Y purinoceptor in the brain.
Simon J; Webb TE; Barnard EA
Pharmacol Toxicol; 1995 May; 76(5):302-7. PubMed ID: 7567779
[TBL] [Abstract][Full Text] [Related]
10. Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.
Jeffs RA; Cooper CL; Harden TK
Mol Pharmacol; 1991 Jul; 40(1):85-92. PubMed ID: 1906978
[TBL] [Abstract][Full Text] [Related]
11. Binding of the radioligand [35S]adenosine 5'-O-(2-thiodiphosphate) and intracellular calcium response in rat liver parenchymal cells.
van Rhee AM; van Winden EC; Nagelkerke JF; de Bont HJ; IJzerman AP; Soudijn W
Biochem Pharmacol; 1993 Feb; 45(4):801-7. PubMed ID: 8452554
[TBL] [Abstract][Full Text] [Related]
12. Distribution and characterisation of [3H]alpha,beta-methylene ATP binding sites in the rat.
Michel AD; Humphrey PP
Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):608-17. PubMed ID: 8133903
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors.
Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
Br J Pharmacol; 1996 Aug; 118(7):1806-12. PubMed ID: 8842447
[TBL] [Abstract][Full Text] [Related]
14. The binding characteristics of a human bladder recombinant P2X purinoceptor, labelled with [3H]-alpha beta meATP, [35S]-ATP gamma S or [33P]-ATP.
Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
Br J Pharmacol; 1996 Mar; 117(6):1254-60. PubMed ID: 8882623
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of a recombinant P2Y purinoceptor.
Simon J; Webb TE; King BF; Burnstock G; Barnard EA
Eur J Pharmacol; 1995 Nov; 291(3):281-9. PubMed ID: 8719412
[TBL] [Abstract][Full Text] [Related]
16. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
Palea S; Corsi M; Pietra C; Artibani W; Calpista A; Gaviraghi G; Trist DG
J Pharmacol Exp Ther; 1994 Apr; 269(1):193-7. PubMed ID: 8169824
[TBL] [Abstract][Full Text] [Related]
17. Evidence for two distinct P2-purinoceptors subserving contraction of the rat anococcygeus smooth muscle.
Najbar AT; Li CG; Rand MJ
Br J Pharmacol; 1996 Jun; 118(3):537-42. PubMed ID: 8762075
[TBL] [Abstract][Full Text] [Related]
18. Relative contribution of P2U- and P2Y-purinoceptors to endothelium-dependent vasodilatation in the golden hamster isolated mesenteric arterial bed.
Ralevic V; Burnstock G
Br J Pharmacol; 1996 Apr; 117(8):1797-802. PubMed ID: 8732294
[TBL] [Abstract][Full Text] [Related]
19. A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.
Ho C; Hicks J; Salter MW
Br J Pharmacol; 1995 Dec; 116(7):2909-18. PubMed ID: 8680724
[TBL] [Abstract][Full Text] [Related]
20. Hydrolysis of P2-purinoceptor agonists by a purified ectonucleotidase from the bovine aorta, the ATP-diphosphohydrolase.
Picher M; Sévigny J; D'Orléans-Juste P; Beaudoin AR
Biochem Pharmacol; 1996 Jun; 51(11):1453-60. PubMed ID: 8630086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
